ConductScience.org, home

Trial · NCT02808819

Results by group72

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Basophils, Full Analysis SetBenra 30 mg q.4 Weeks0.014Standard Deviation 0.022910^9 cells/L
Change From Baseline in Basophils, Full Analysis SetBenra 30 mg q.8 Weeks0.012Standard Deviation 0.024310^9 cells/L
Change From Baseline in Basophils, Full Analysis SetTotal0.013Standard Deviation 0.023610^9 cells/L
Change From Baseline in Leukocytes, Full Analysis SetBenra 30 mg q.4 Weeks-0.254Standard Deviation 2.044610^9 cells/L
Change From Baseline in Leukocytes, Full Analysis SetBenra 30 mg q.8 Weeks-0.498Standard Deviation 1.721710^9 cells/L
Change From Baseline in Leukocytes, Full Analysis SetTotal-0.377Standard Deviation 1.889610^9 cells/L
Change From Baseline in Lymphocytes, Full Analysis SetBenra 30 mg q.4 Weeks-0.098Standard Deviation 0.547910^9 cells/L
Change From Baseline in Lymphocytes, Full Analysis SetBenra 30 mg q.8 Weeks-0.142Standard Deviation 0.654410^9 cells/L
Change From Baseline in Lymphocytes, Full Analysis SetTotal-0.121Standard Deviation 0.603810^9 cells/L
Change From Baseline in Neutrophils, Full Analysis SetBenra 30 mg q.4 Weeks-0.237Standard Deviation 1.876510^9 cells/L
Change From Baseline in Neutrophils, Full Analysis SetBenra 30 mg q.8 Weeks-0.392Standard Deviation 1.480210^9 cells/L
Change From Baseline in Neutrophils, Full Analysis SetTotal-0.315Standard Deviation 1.686610^9 cells/L
Change From Baseline in Monocytes, Full Analysis SetBenra 30 mg q.4 Weeks0.055Standard Deviation 0.183510^9 cells/L
Change From Baseline in Monocytes, Full Analysis SetBenra 30 mg q.8 Weeks0.056Standard Deviation 0.176610^9 cells/L
Change From Baseline in Monocytes, Full Analysis SetTotal0.055Standard Deviation 0.179810^9 cells/L
Change From Baseline in Platelets, Full Analysis SetBenra 30 mg q.4 Weeks9.1Standard Deviation 41.7210^9 cells/L
Change From Baseline in Platelets, Full Analysis SetBenra 30 mg q.8 Weeks11.9Standard Deviation 36.1310^9 cells/L
Change From Baseline in Platelets, Full Analysis SetTotal10.5Standard Deviation 38.9810^9 cells/L
Change From Baseline in Hematocrit, Full Analysis SetBenra 30 mg q.4 Weeks-0.002Standard Deviation 0.0269[ratio]
Change From Baseline in Hematocrit, Full Analysis SetBenra 30 mg q.8 Weeks-0.003Standard Deviation 0.0260[ratio]

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02808819/results